Skip to content

FP7H2020

Osm-Dan Ltd

Country
ILIsrael
Defence projects
0
Projects, all programmes
16
As coordinator
0
EU contribution (CORDIS)
EUR 4,002,994
Active
2008 to 2021

Projects

16 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
BIOMATAn Open Innovation Test Bed for Nano-Enabled Bio-Based PUR Foams and CompositesH20202021ParticipantEUR 510,475
EDITNovel precision technological platforms to promote non-invasive early diagnosis, eradication and prevention of cancer relapse: proof of concept in the bladder carcinoma.H20202018ParticipantEUR 216,364
ReInventNovel Products for Construction and Automotive Industries Based on Bio Materials and Natural FibresH20202018ParticipantEUR 349,562
PROTECTPre-commercial lines for production of surface nanostructured antimicrobial and anti-biofilm textiles, medical devices and water treatment membranesH20202017ParticipantEUR 337,575
InFactFunctional materials for fast diagnosis of wound infectionFP72014ParticipantEUR 199,080
SuperFlexDevelop and demonstrate a ‘Mini-factory’ concept for production of personalized skin care products for elderly populationFP72013ParticipantEUR 277,088
ALLOXIDEPVNovel Composite Oxides by Combinatorial Material Synthesis for Next Generation All-Oxide-PhotovoltaicsFP72012ParticipantEUR 165,560
NOVONovel approaches for prevention and degeneration of pathogenic bacteria biofilms formed on medical devices e.g. cathetersFP72012ParticipantEUR 219,410
IN-SIGHTIn-line characterisation of nanoparticles using a combination of analytical techniques in real timeFP72011ParticipantEUR 165,600
SAVEMEA Modular Nanosystems Platform for Advanced Cancer Management: Nano-vehicles; Tumor Targeting and Penetration Agents; Molecular Imaging, Degradome based TherapyFP72011ParticipantEUR 381,640
NPMIMETICBiomimetic nano-fiber-based nucleus pulposus regeneration for the treatment of degenerative disc diseaseFP72011ParticipantEUR 215,640
EPOCANGaining sage on the Epoetins' saga: assessing long term risks and advancing towards better Epoetin driven treatment modalitiesFP72011ParticipantEUR 120,460
CADMADPaving the Way for Future Emerging DNA-based Technologies: Computer-Aided Design and Manufacturing of DNA librariesFP72011ParticipantEUR 133,780
SONOA pilot line of antibacterial and antifungal medical textiles based on a sonochemical processFP72009ParticipantEUR 350,280
RECBREEDRecombination: an old and new tool for plant breedingFP72009ParticipantEUR 180,480
SKIN TREATNovel approaches for the development of customized skin treatments and services (Test case: Dead Sea Minerals and Conventional drugs)FP72008ParticipantEUR 180,000

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.